Want to see JP:9341 full AI Analyst Report?
9341 Stock Chart & Stats
¥582.00
-¥9.00(-0.65%)
At close: 4:00 PM EST
¥582.00
-¥9.00(-0.65%)
Day’s Range― - ―
52-Week Range¥541.00 - ¥704.00
Previous CloseN/A
Volume164.20K
Average Volume (3M)84.37K
Market Cap
¥11.10B
Enterprise Value¥6.87K
Total Cash (Recent Filing)¥5.08B
Total Debt (Recent Filing)¥1.77B
Price to Earnings (P/E)17.5
Beta0.79
Next Earnings
Nov 12, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield4.78%
Share Statistics
EPS (TTM)35.97
Shares Outstanding17,838,100
10 Day Avg. Volume89,330
30 Day Avg. Volume84,373
Financial Highlights & Ratios
PEG Ratio-0.43
Price to Book (P/B)1.38
Price to Sales (P/S)0.82
P/FCF Ratio-202.80
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)157.5
Revenue Forecast (FY)¥15.40B
Bulls Say, Bears Say
Bulls Say
Sustained Revenue GrowthRevenue growth remains strong and has continued across multiple years, indicating sustained demand and expanding market reach. Continued scale could support stronger competitive positioning and improve operating leverage over the next several quarters.
Modest LeverageConservative leverage reduces balance-sheet risk and preserves financial flexibility. A large equity base should help the company fund growth and absorb earnings volatility without relying excessively on additional borrowing.
Healthy Asset GrowthA growing asset base indicates that the business has expanded its operating platform over time. This supports greater scale and capacity, providing a durable foundation for serving demand and sustaining the company’s longer-term growth trajectory.
Bears Say
Sharp Margin CompressionThe broad deterioration in gross, operating, and net margins signals weaker profitability and reduced earnings quality. Unless reversed, structurally lower margins could limit operating leverage, reduce resilience, and make future earnings less predictable.
Negative Free Cash FlowWeak cash conversion means reported earnings are not translating efficiently into cash. Negative free cash flow can constrain reinvestment, dividends, and financial flexibility, while also raising the risk that working-capital or investment demands persist.
ROE DeteriorationThe steep ROE decline shows that the company is generating substantially less profit from its equity base. This weakens capital efficiency and suggests that the current balance-sheet scale is not yet producing returns comparable with prior periods.
GENOVA Inc. News
9341 FAQ
What was GENOVA Inc.’s price range in the past 12 months?
GENOVA Inc. lowest stock price was ¥541.00 and its highest was ¥704.00 in the past 12 months.
What is GENOVA Inc.’s market cap?
GENOVA Inc.’s market cap is ¥11.10B.
When is GENOVA Inc.’s upcoming earnings report date?
GENOVA Inc.’s upcoming earnings report date is Nov 12, 2026 which is in 68 days.
How were GENOVA Inc.’s earnings last quarter?
GENOVA Inc. released its earnings results on Aug 10, 2026. The company reported ¥14.4 earnings per share for the quarter.
Is GENOVA Inc. overvalued?
According to Wall Street analysts GENOVA Inc.’s price is currently Overvalued.
Does GENOVA Inc. pay dividends?
GENOVA Inc. pays a Notavailable dividend of ¥30 which represents an annual dividend yield of 4.78%. See more information on GENOVA Inc. dividends here
What is GENOVA Inc.’s EPS estimate?
GENOVA Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GENOVA Inc. have?
GENOVA Inc. has 17,838,100 shares outstanding.
What happened to GENOVA Inc.’s price movement after its last earnings report?
GENOVA Inc. reported an EPS of ¥14.4 in its last earnings report. Following the earnings report the stock price went up 2.073%.
Which hedge fund is a major shareholder of GENOVA Inc.?
Currently, no hedge funds are holding shares in JP:9341
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
GENOVA Inc.
Operating within Japan, GENOVA, Inc. focuses on the digital healthcare market, providing both medical platform services and smart clinic solutions. Its offerings include Medical Doc, a comprehensive online platform that distributes diverse content, such as articles for healthcare institutions, patient experience narratives, treatment demonstrations, and general medical information. The company also developed Smart Clinic, an innovative telemedicine and consultation service that enables users to receive medical care from their homes or workplaces, bypassing the need for in-person hospital visits. Additionally, GENOVA offers a suite of clinic automation tools, including NOMOCa-Stand, a user-friendly automatic machine for reception and payments; NOMOCa-Regi, a dedicated self-pay terminal for clinic environments; and CLINIC BOT, an AI-driven chatbot system. GENOVA, Inc. was established in 2005 and is based in Tokyo, Japan.
Technical Analysis
Medley
―
―
Welby Inc.
―
Mental Health Technologies Co. Ltd.
―
Wellness Communications Corporation
―